+Search query
-Structure paper
Title | Novel mesothelin antibodies enable crystallography of the intact mesothelin ectodomain and engineering of potent, T cell-engaging bispecific therapeutics |
---|---|
Journal, issue, pages | Front. Drug Discov., Vol. 3, Year 2023 |
Publish date | May 20, 2022 (structure data deposition date) |
Authors | Lin, I. / Rupert, P.B. / Pilat, K. / Ruff, R.O. / Friend, D.J. / Chan, M.K. / Clarke, M. / Hoffstrom, B.G. / Carter, J. / Meshinchi, S. ...Lin, I. / Rupert, P.B. / Pilat, K. / Ruff, R.O. / Friend, D.J. / Chan, M.K. / Clarke, M. / Hoffstrom, B.G. / Carter, J. / Meshinchi, S. / Bandaranayake, A.D. / Mehlin, C. / Olson, J.M. / Strong, R.K. / Correnti, C.E. |
External links | Front. Drug Discov. / Search PubMed |
Methods | X-ray diffraction |
Resolution | 2.6 - 4.31 Å |
Structure data | PDB-8cxc: PDB-8cyh: PDB-8cz8: |
Chemicals | ChemComp-NAG: ChemComp-SO4: ChemComp-HOH: |
Source |
|
Keywords | ANTITUMOR PROTEIN / Antibody / complex / tumor associated antigen |